These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18579602)

  • 61. Protection against lethal influenza virus challenge by RNA interference in vivo.
    Tompkins SM; Lo CY; Tumpey TM; Epstein SL
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8682-6. PubMed ID: 15173583
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
    Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
    Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevention of influenza by targeting host receptors using engineered proteins.
    Connaris H; Govorkova EA; Ligertwood Y; Dutia BM; Yang L; Tauber S; Taylor MA; Alias N; Hagan R; Nash AA; Webster RG; Taylor GL
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6401-6. PubMed ID: 24733924
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-influenza virus activity of tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone.
    Yazawa K; Kurokawa M; Obuchi M; Li Y; Yamada R; Sadanari H; Matsubara K; Watanabe K; Koketsu M; Tuchida Y; Murayama T
    Antivir Chem Chemother; 2011 Aug; 22(1):1-11. PubMed ID: 21860068
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protection of three strains of mice against lethal influenza in vivo by defective interfering virus.
    Morgan DJ; McLain L; Dimmock NJ
    Virus Res; 1993 Aug; 29(2):179-83. PubMed ID: 8212859
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein.
    Huang F; Chen J; Zhang J; Tan L; Lu G; Luo Y; Pan T; Liang J; Li Q; Luo B; Zhang H; Lu G
    J Cell Mol Med; 2018 Mar; 22(3):1826-1839. PubMed ID: 29193684
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Zoonotic Risk, Pathogenesis, and Transmission of Avian-Origin H3N2 Canine Influenza Virus.
    Sun H; Blackmon S; Yang G; Waters K; Li T; Tangwangvivat R; Xu Y; Shyu D; Wen F; Cooley J; Senter L; Lin X; Jarman R; Hanson L; Webby R; Wan XF
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814512
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice.
    Miller SM; Cybulski V; Whitacre M; Bess LS; Livesay MT; Walsh L; Burkhart D; Bazin HG; Evans JT
    Front Immunol; 2020; 11():406. PubMed ID: 32210973
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
    Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses.
    Park S; Kim JI; Lee I; Lee S; Hwang MW; Bae JY; Heo J; Kim D; Han SZ; Park MS
    Biochem Biophys Res Commun; 2013 Oct; 440(1):14-9. PubMed ID: 24012672
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influenza A virus replication induces cell cycle arrest in G0/G1 phase.
    He Y; Xu K; Keiner B; Zhou J; Czudai V; Li T; Chen Z; Liu J; Klenk HD; Shu YL; Sun B
    J Virol; 2010 Dec; 84(24):12832-40. PubMed ID: 20861262
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiviral Effects of ABMA and DABMA against Influenza Virus In Vitro and In Vivo via Regulating the Endolysosomal Pathway and Autophagy.
    Liu H; Jiang C; Wu Y; Wu M; Wu J; Zhao G; Sun J; Huang X; Li J; Sheng R; Barbier J; Cintrat JC; Gillet D; Su W
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409297
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia.
    Tuvim MJ; Gilbert BE; Dickey BF; Evans SE
    PLoS One; 2012; 7(1):e30596. PubMed ID: 22299046
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes.
    White MR; Kandel R; Tripathi S; Condon D; Qi L; Taubenberger J; Hartshorn KL
    PLoS One; 2014; 9(7):e101364. PubMed ID: 24988208
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chronic alcohol consumption increases the severity of murine influenza virus infections.
    Meyerholz DK; Edsen-Moore M; McGill J; Coleman RA; Cook RT; Legge KL
    J Immunol; 2008 Jul; 181(1):641-8. PubMed ID: 18566431
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.
    Frensing T; Heldt FS; Pflugmacher A; Behrendt I; Jordan I; Flockerzi D; Genzel Y; Reichl U
    PLoS One; 2013; 8(9):e72288. PubMed ID: 24039749
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles.
    Hein MD; Arora P; Marichal-Gallardo P; Winkler M; Genzel Y; Pöhlmann S; Schughart K; Kupke SY; Reichl U
    BMC Biol; 2021 May; 19(1):91. PubMed ID: 33941189
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survival of influenza virus on banknotes.
    Thomas Y; Vogel G; Wunderli W; Suter P; Witschi M; Koch D; Tapparel C; Kaiser L
    Appl Environ Microbiol; 2008 May; 74(10):3002-7. PubMed ID: 18359825
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice.
    Moseley CE; Webster RG; Aldridge JR
    Influenza Other Respir Viruses; 2010 Sep; 4(5):307-11. PubMed ID: 20716159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.